Literature DB >> 21584287

Cyclic enkephalin-deltorphin hybrids containing a carbonyl bridge: structure and opioid activity.

Małgorzata Ciszewska1, Katarzyna Ruszczyńska, Marta Oleszczuk, Nga N Chung, Ewa Witkowska, Peter W Schiller, Jacek Wójcik, Jan Izdebski.   

Abstract

Six hybrid N-ureidoethylamides of octapeptides in which an N-terminal cyclic structure related to enkephalin was elongated by a C-terminal fragment of deltorphin were synthesized on MBHA resin. The synthetic procedure involved deprotection of Boc groups with HCl/dioxane and cleavage of the peptide resin with 45 % TFA in DCM. d-Lys and d-Orn were incorporated in position 2, and Lys, Orn, Dab, or Dap in position 5. The side chains of the dibasic amino function were protected with the Fmoc group. This protection was removed by treatment with 55 % piperidine in DMF, and cyclization was achieved by treatment with bis-(4-nitrophenyl)carbonate. Using various combinations of dibasic amino acids, peptides containing a 17-, 18-, 19- or 20-membered ring structure were obtained. The peptides were tested in the guinea-pig ileum (GPI) and mouse vas deferens (MVD) assays. Diverse opioid activities were observed, depending on the size of the ring. Extension of the enkephalin sequence at the C-terminus by a deltorphin fragment resulted in a change of receptor selectivity in favor of the δ receptor. The conformational propensities of selected peptides were determined using the EDMC method in conjunction with data derived from NMR experiments carried out in water. This approach allowed proper examination of the dynamical behavior of these small peptides. The results were compared with those obtained earlier with corresponding N-(ureidoethyl)pentapeptide amides.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21584287      PMCID: PMC3229099     

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  30 in total

Review 1.  The cyclization of peptides and depsipeptides.

Authors:  John S Davies
Journal:  J Pept Sci       Date:  2003-08       Impact factor: 1.905

2.  Unsulfated C-terminal 7-peptide of cholecystokinin: a new ligand of the opiate receptor.

Authors:  P W Schiller; A Lipton; D F Horrobin; M Bodanszky
Journal:  Biochem Biophys Res Commun       Date:  1978-12-29       Impact factor: 3.575

3.  Opioid activities of fragments of beta-endorphin and of its leucine65-analogue. Comparison of the binding properties of methionine- and leucine-enkephalin.

Authors:  A A Waterfield; F M Leslie; J A Lord; N Ling; H W Kosterlitz
Journal:  Eur J Pharmacol       Date:  1979-09-01       Impact factor: 4.432

4.  p-Nitrophenoxycarbonyl derivatives of Boc-protected diaminoalkanes in the synthesis of enkephalin peptidomimetics.

Authors:  Anna Wiszniewska; Danuta Kunce; Nga N Chung; Peter W Schiller; Jan Izdebski
Journal:  J Pept Sci       Date:  2005-09       Impact factor: 1.905

5.  Cyclic enkephalin and dermorphin analogues containing a carbonyl bridge.

Authors:  Katarzyna Filip; Marta Oleszczuk; Jacek Wójcik; Nga N Chung; Peter W Schiller; Danuta Pawlak; Agnieszka Zieleniak; Agnieszka Parcińska; Ewa Witkowska; Jan Izdebski
Journal:  J Pept Sci       Date:  2005-06       Impact factor: 1.905

6.  N-(ureidoethyl)amides of cyclic enkephalin analogs.

Authors:  Małgorzata Ciszewska; Maria Kwasiborska; Michał Nowakowski; Marta Oleszczuk; Jacek Wójcik; Nga N Chung; Peter W Schiller; Jan Izdebski
Journal:  J Pept Sci       Date:  2009-04       Impact factor: 1.905

7.  Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.

Authors:  S Charpentier; S Sagan; A Delfour; P Nicolas
Journal:  Biochem Biophys Res Commun       Date:  1991-09-30       Impact factor: 3.575

8.  1H, 13C and 15N chemical shift referencing in biomolecular NMR.

Authors:  D S Wishart; C G Bigam; J Yao; F Abildgaard; H J Dyson; E Oldfield; J L Markley; B D Sykes
Journal:  J Biomol NMR       Date:  1995-09       Impact factor: 2.835

9.  Enkephalin derivative, cyclo[Nepsilon,Nbeta-carbonyl-D-Lys2, Dap5] enkephalinamide (cUENK6), induces a highly potent antinociception in rats.

Authors:  Jolanta Kotlinska; Marcin Bochenski; Monika Lagowska-Lenard; Ewa Gibula-Bruzda; Ewa Witkowska; Jan Izdebski
Journal:  Neuropeptides       Date:  2009-04-18       Impact factor: 3.286

10.  A cyclic enkephalin analog with high in vitro opiate activity.

Authors:  J DiMaio; P W Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  1 in total

Review 1.  Cyclic Opioid Peptides.

Authors:  Michael Remesic; Yeon Sun Lee; Victor J Hruby
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.